U.S. Hotel and Resort REITs Stock News

NYSE:VSH
NYSE:VSHElectronic

A Look At Vishay Intertechnology (VSH) Valuation After Recent Share Price Swings

Why Vishay Intertechnology (VSH) Is On Investors’ Radar Today Vishay Intertechnology (VSH) is drawing attention after recent share price moves that include a gain over the past 3 months alongside a month pullback, putting its current US$17.23 price in focus. See our latest analysis for Vishay Intertechnology. That recent 3 month share price return of 13.73% sits alongside a 30 day share price pullback of 8.74% and a more modest 1 year total shareholder return of 4.82%. Together, these figures...
NYSE:MKC
NYSE:MKCFood

A Look At McCormick (MKC) Valuation After Analyst Downgrade And Margin Concerns

McCormick (MKC) has been in focus after a recent analyst downgrade to strong sell. The move pulled the stock lower and sharpened attention on its 2026 outlook for margins, tariffs, and commodity costs. See our latest analysis for McCormick. Beyond this downgrade, McCormick’s latest share price of $58.29 comes after a 1 month share price return of 18.46% decline and a 1 year total shareholder return of 25.54% decline, suggesting sentiment has weakened even as it launches new products like the...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

Assessing Vicor (VICR) Valuation After Multi Period Share Price Momentum

Vicor stock moves after strong multi period returns Vicor (VICR) has drawn fresh attention after a sharp move in its share price, with the stock showing gains over the past week, month, past 3 months and on a 1 year and multi year basis. See our latest analysis for Vicor. At the current share price of $172.57, Vicor’s recent 90 day share price return of 80.53% and 1 year total shareholder return of 221.60% point to strong momentum that has built over time rather than a short term spike. If...
NasdaqGS:LASR
NasdaqGS:LASRElectronic

Does nLIGHT (LASR) Leadership Trading Align With Its Expanding Defense-Laser Ambitions?

Earlier this month, nLIGHT, Inc. showcased its new 70kW-class Laser Weapon System and recently released 30kW and 10kW high-energy lasers at the Pacific Operational Science & Technology Conference in Honolulu, highlighting its vertically integrated approach to defense-grade laser manufacturing. At the same time, CEO Scott H. Keeney’s US$1.1 million stock sale under a Rule 10b5-1 plan has drawn attention to how insider transactions sit alongside strong recent growth in aerospace, defense, and...
NYSE:AVA
NYSE:AVAIntegrated Utilities

Is It Time To Reconsider Avista (AVA) After Recent Share Price Weakness?

If you are wondering whether Avista's current share price lines up with its underlying value, this article will walk through what the key numbers are really saying. Over the past week Avista has a 0.5% return, compared with a 7.5% decline over the last 30 days and returns of 3.0% year to date and 4.9% over 1 year, with a 3 year return of 11.7% and 5 year return of 8.8% that can help frame how the current US$39.87 share price fits into its recent history. Recent price moves have come against...
NYSE:CLH
NYSE:CLHCommercial Services

How Investors Are Reacting To Clean Harbors (CLH) Record Free Cash Flow And $250M Buyback Plan

In recent days, Clean Harbors reported record free cash flow in 2025, continued multi-year margin expansion in its Environmental Services segment, and announced plans for US$250,000,000 in share buybacks alongside refreshed analyst coverage signaling confidence in its operations. The news also underscores how growing demand for PFAS remediation and services linked to reshoring manufacturing is increasingly central to Clean Harbors’ role in the environmental services ecosystem. We’ll now...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Valuation After China GLP‑1 Expansion And Tirzepatide Safety Push

Eli Lilly (LLY) is back in focus after outlining a US$3b, decade-long investment in China tied to its oral GLP-1 drug orforglipron, while separately pressing U.S. regulators on compounded tirzepatide safety. See our latest analysis for Eli Lilly. Despite a series of obesity drug launches, access initiatives, legal headlines and this new US$3b China plan, Eli Lilly’s short term share price performance has cooled. The company has seen a 30 day share price decline of 5.28% and a year to date...
NYSE:EMN
NYSE:EMNChemicals

A Look At Eastman Chemical (EMN) Valuation As Expanded Self Help Plan Draws Bullish Analyst Support

Eastman Chemical (EMN) is back in focus after management expanded its 2026 self help plan, pairing higher targeted cost reductions with an emphasis on cash generation and capital returns that analysts have recently highlighted. See our latest analysis for Eastman Chemical. At a share price of US$69.25, Eastman Chemical has a 30 day share price return of 13.52% decline but a 90 day share price return of 8.29% gain. The 1 year total shareholder return of 20.23% loss and 5 year total shareholder...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

How Do Lending Curbs and ESOP Moves Reframe TPG (TPG)’s Private Credit Risk Profile?

Earlier this month, TPG Inc. filed a US$282.34 million shelf registration for 6,383,349 Class A shares tied to its employee stock ownership plan, while the firm also contended with sector-wide stress after JPMorgan Chase moved to restrict lending to private credit providers and TPG limited redemptions on key funds. At the same time, TPG’s climate platform completed a complex exit from Intersect to Google, reshaping its exposure to fast-growing data center and clean power infrastructure...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

How Investors May Respond To CG Oncology (CGON) Expanding ATM Offering To Advance Cretostimogene BLA Efforts

In recent days, CG Oncology drew attention as multiple research firms updated their views on the company, while it expanded its at-the-market stock offering to up to US$550 million to support progress toward a Biologics License Application for its bladder cancer therapy candidate, cretostimogene. Analysts pointed to recent clinical and market validation in intermediate-risk non-muscle invasive bladder cancer and CG Oncology’s advancing PIVOT-006 trial as important factors shaping how...
NYSE:DAO
NYSE:DAOConsumer Services

Assessing Youdao (DAO) Valuation After The Launch Of Its Open-Source Lobster AI Agent

Why Youdao’s New AI Agent Matters for Investors Youdao (NYSE:DAO) has launched Youdao Lobster, described as China’s first fully open-source AI Agent, featuring a 5,000 plus skill store and integration with popular office messaging platforms. This launch highlights Youdao’s push into AI based tools and gives investors a fresh development to assess alongside the company’s existing learning services, smart devices, and online marketing businesses in China. See our latest analysis for...
NYSE:ATHM
NYSE:ATHMInteractive Media and Services

How Investors May Respond To Autohome (ATHM) Buybacks Amid Softer 2025 Earnings

Autohome Inc. recently reported fourth-quarter and full-year 2025 results showing lower revenue and net income year over year, while also confirming that it completed a prior buyback of 7,116,939 shares for US$184.50 million. On the same day, the Board authorized a new share repurchase program of up to US$200 million funded from existing cash, highlighting management’s continued focus on capital returns even as earnings softened. Now we’ll explore how the new US$200 million repurchase plan,...
NYSE:FLG
NYSE:FLGBanks

A Look At Flagstar Bank (FLG) Valuation After Recent Share Price Weakness

Flagstar Bank National Association (FLG) has drawn fresh attention after recent trading left the shares with a 14% decline over the past month and a 6.8% decline over the past 3 months. See our latest analysis for Flagstar Bank National Association. That recent 14% one-month share price decline and 6.8% three-month share price decline come against a relatively flat year-to-date share price return of a 2.8% decline. The 1-year total shareholder return of 3.2% and 3-year total shareholder...
NYSE:PSX
NYSE:PSXOil and Gas

How New Board Appointments And Crude Sourcing Moves At Phillips 66 (PSX) Have Changed Its Investment Story

Earlier this month, Phillips 66 appointed Howard Ungerleider and Kevin Meyers to its Board of Directors and continued engaging investors through appearances at major energy conferences, following a period of strong quarterly earnings and a higher US$1.27 dividend per share. These leadership additions, combined with Phillips 66’s efforts to secure more efficient crude sourcing and enhance refining margins, are reshaping how investors view the company’s long-term earnings profile and...
NYSE:CMS
NYSE:CMSIntegrated Utilities

How CMS Energy’s 20-Year Clean Energy Buildout Could Reshape the Outlook for CMS Investors

In recent days, Consumers Energy, a CMS Energy subsidiary, outlined an Integrated Resource Plan featuring more than 13 GW of additional renewables and clean energy resources, including solar, battery storage, wind, and two new natural gas plants totaling 1.5 GW to support Michigan’s electricity needs over the next 20 years. Beyond power reliability and customer bill reductions, the plan’s projected creation of thousands of construction and permanent jobs and an almost US$19.00 billion boost...
NYSE:SCI
NYSE:SCIConsumer Services

The Bull Case For Service Corporation International (SCI) Could Change Following Q4 Miss, Dividend And Insider Sale

Service Corporation International recently reported fourth-quarter 2025 results that fell short of analyst expectations on both adjusted earnings per share and revenue, while its board approved a US$0.34 per-share quarterly dividend paid on March 31, 2026, and Director Tony Coelho sold 7,700 shares on March 10, 2026. This combination of an earnings miss alongside continued dividend payments and insider selling raises questions about how resilient the company’s underlying cash generation and...
NYSE:MPC
NYSE:MPCOil and Gas

Assessing Marathon Petroleum (MPC) Valuation After Q4 Earnings Beat And Record Refining Margins

Marathon Petroleum (MPC) has drawn fresh investor attention after reporting Q4 2025 adjusted earnings of $4.07 per share, record refining margins in its Refining & Marketing segment, and returning $1.3 billion to shareholders. See our latest analysis for Marathon Petroleum. The latest Q4 beat and record refining margins come on top of strong recent share price momentum, with a 30-day share price return of 11.28% and a 90-day gain of 21.92%. The 1-year total shareholder return of 63.68% and...
NYSE:GDDY
NYSE:GDDYIT

Why GoDaddy (GDDY) Is Down 13.5% After Analyst Downgrade On AI, Growth And Leverage Concerns

Recently, an analyst downgraded GoDaddy, citing accelerating disruption in its core markets, slowing revenue and bookings growth, limited visible benefits from its AI products, and rising leverage linked to aggressive share repurchases. The downgrade also highlighted that some competitors, such as Wix, appear better positioned in terms of growth and AI adoption, sharpening questions about GoDaddy’s competitive standing in key segments. Next, we’ll explore how concerns about slowing growth...
NYSE:VIA
NYSE:VIASoftware

Via Transportation (VIA) Valuation Check After Recent Share Price Weakness

Recent price performance and business snapshot Via Transportation (VIA) has drawn attention after its share price declined about 7% over the past week and roughly 43% over the past 3 months, putting recent trading under closer investor review. The New York based transit software company reports annual revenue of US$434.3 million and a net loss of US$96.4 million. Its services span planning tools, operations software, and tech enabled transit solutions for public and private clients. See our...
NasdaqGS:CERT
NasdaqGS:CERTHealthcare Services

Assessing Certara (CERT) Valuation After FDA PBPK Milestone And New Biosimulation Software Launches

Certara (CERT) is back on investors’ radar after closing 2025 with revenue of US$418.8m, a small net loss, and fresh FDA validation of its biosimulation platform through PBPK modeling used in the asciminib NDA. See our latest analysis for Certara. Despite FDA validation for its PBPK work and new software launches, Certara’s share price has been under pressure, with a 90 day share price return of 23.91% and a 1 year total shareholder return of 39.10%. This may indicate fading momentum after...
NYSE:ABBV
NYSE:ABBVBiotechs

Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness

What AbbVie’s Recent Performance Tells You Right Now AbbVie (ABBV) has drawn investor attention after a period of weaker share performance, with the stock showing declines over the past week, month, and past 3 months despite a positive 1 year total return. See our latest analysis for AbbVie. Short term momentum has cooled, with a 1 day share price return of 2.52% decline and a 30 day share price return of 5.11% decline, even though AbbVie’s 5 year total shareholder return of 157.21% reflects...
NYSE:AMT
NYSE:AMTSpecialized REITs

Assessing American Tower (AMT) Valuation After Dividend Increase And CoreSite Expansion Progress

American Tower (AMT) is back in focus after its Board declared a quarterly cash distribution of $1.79 per share, prompting investors to reassess the stock’s income profile and recent share price moves. See our latest analysis for American Tower. The dividend decision lands as American Tower’s 1 day share price return of 2.53% contrasts with a 30 day share price return decline of 4.00% and a 1 year total shareholder return decline of 9.50%, hinting that near term momentum is firming while...
NYSE:BHE
NYSE:BHEElectronic

Will Benchmark Electronics (BHE) CEO’s New Outside Board Seat Subtly Reframe Its Capital Priorities?

Benchmark Electronics recently announced that its President and CEO, Jeffrey Benck, has joined the board of directors at Crane NXT, adding an external governance role to his responsibilities at the company. This cross-board appointment underscores the growing influence of Benchmark Electronics’ leadership across the industrial technology landscape and raises questions about how Benck’s expanded network could shape corporate priorities. We’ll now examine how Jeffrey Benck’s new Crane NXT...
NYSE:SVV
NYSE:SVVMultiline Retail

A Look At Savers Value Village (SVV) Valuation After Insider Trades And Strong Preliminary Q4 Sales

Savers Value Village (SVV) is back on investors’ radar after President and COO Jubran N. Tanious exercised options for 100,000 shares and sold 45,000 shares, along with preliminary fourth quarter comparable sales updates. See our latest analysis for Savers Value Village. At a share price of $7.88, Savers Value Village has a 1 day share price return of 1.03%, while the 30 day share price return of 30.20% and year to date share price return of 16.61% suggest recent momentum has faded. However,...